Idiopathic Pulmonary Fibrosis: Large Clinical Trial Finds Pirfenidone May Help Lung Function In IPF Patients
Sunday, May 17, 2009 - 15:21
in Health & Medicine
A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis.
Read the whole article on Science Daily
More from Science Daily
Related
- Large clinical trial finds pirfenidone may help lung function in IPF patientsSun, 17 May 2009, 13:42:52 EDT
- The risk factors of idiopathic pulmonary fibrosis in HCV patientsThu, 23 Oct 2008, 9:56:53 EDT
- Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patientsTue, 7 Jul 2009, 5:28:37 EDT
- New treatment gives hope for pulmonary fibrosis patientsTue, 20 May 2008, 8:49:14 EDT
- In brief: New prognostic indicator for patients with IPFFri, 20 Feb 2009, 9:09:42 EST